Investigating Biological Targets, Markers, and Intervention for Chronic Pain
CompletedNot applicableNCT04625504
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This multi-modal methods study will investigate neurophysiological, endocrinological, cognitive, psycho-social-emotional markers of chronic pain, and therapeutic targets using integrative health treatments.
Study details
- Official title
- Investigating Biological Targets, Markers, and Intervention for Chronic Pain
- Interventions
- Behavioral: Mindfulness Based Intervention
- Sponsor
- Vanderbilt University Medical Center
- Start date
- 2020-11-25
- Primary completion
- 2022-07-28
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria for Chronic Pain Patients: * Age range: 18-60 years * Must indicate pain intensity of 3/10 and must have experienced pain for at least 3 months * Must possess English language skills sufficient for providing informed consent, completing questionnaires, and understanding instructions * Must have a stable medication regimen or no medication or dosage changes within the past month Blood Collection Inclusion: * At least 110 pounds * Generally healthy by self-report on day of collection (i.e., free of cold and flu symptoms on the day of collection, no infections within two weeks prior to collection, no known sickle cell disease) * Including the study draw, blood donation for clinical or research purposes within the preceding eight weeks will not exceed 550 mL * No more than one blood draw will have occurred during the preceding week Exclusion Criteria for Chronic Pain Patients: * Prior diagnosis of bipolar I, bipolar II, psychotic personality disorder, borderline personality disorder, and/or narcissistic personality disorder * Current history (equal/less than 6 months) of substance abuse/dependence * Current history (equal/less than 6 months) of regular meditation practice (\>1 session/week; \>10 min/session) * Diagnosis of bipolar I, bipolar II, psychotic personality disorder, borderline personality disorder, and/or narcissistic personality disorder * History of medical illness associated with possible changes in cerebral tissue or cerebrovasculature (e.g., stroke) or with neurologic abnormality (e.g., seizure disorder, cerebrovascular or neoplastic lesion, neurodegenerative disorder, or significant head trauma, defined by loss of consciousness of ≥ 5 minutes) * Current suicidal ideation Exclusion Criteria for Healthy Controls: * Current history (equal/less than 6 months) of substance abuse/dependence * No major medical illness. History of medical illness associated with possible changes in cerebral tissue or cerebrovasculature (e.g., stroke) or with neurologic abnormality (e.g., seizure disorder, cerebrovascular or neoplastic lesion, neurodegenerative disorder, or significant head trauma, defined by loss of consciousness of ≥ 5 minutes) * Current suicidal ideation * Current history (equal/less than 6 months) of regular meditation practice (\>1 session/week; \>10 min/session)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04625504